Expression of activation molecules in neutrophils, monocytes and lymphocytes from patients with unstable angina treated with stent implantation

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 3, 2004, Pages 273-278

  Sánchez Margalet, Victor ^a   Cubero, José M ^a   Martín Romero, Consuelo ^a   Cubero, José ^a   Cruz Fernández, José M ^a   Goberna, Raimundo ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Activation marker; Coronary artery disease; Inflammation; Leukocyte; Percutaneous transluminal coronary angioplasty (PTCA); Stent; Unstable angina

Indexed keywords

BIOCHEMICAL MARKER; CD11B ANTIGEN; CD18 ANTIGEN; CD38 ANTIGEN; CELL SURFACE MARKER;

ARTICLE; BLOOD SAMPLING; CELL ACTIVATION; CONTROLLED STUDY; CORONARY STENT; CORRELATION ANALYSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MONOCYTE; NEUTROPHIL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ADP-RIBOSYL CYCLASE; ANGINA, UNSTABLE; ANGIOPLASTY; ANTIGENS, CD; ANTIGENS, CD11B; ANTIGENS, CD18; ANTIGENS, CD38; DATA INTERPRETATION, STATISTICAL; FLOW CYTOMETRY; HUMANS; INFLAMMATION; LEUKOCYTES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MACROPHAGE ACTIVATION; MEMBRANE GLYCOPROTEINS; MONOCYTES; NEUTROPHIL ACTIVATION; NEUTROPHILS; STENTS;

ANGINA;

EID: 1842787637     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.050     Document Type: Article

References (35)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
2. Berliner JAB, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, et al. Atherosclerosis: basic mechanisms, oxidation, inflammation, and genetics. Circulation 1995;91:2488-96.
3. Berk BC, Weintraub WS, Alexander RW. Elevation of c-reactive protein in "active" coronary artery disease. Am J Cardiol 1990;65:168-72.
4. Rifai N, Joubran R, Yu H, Asmi M, Jouma M. Inflammatory markers in men with angiographically documented coronary heart disease. Clin Chem 1999;45:1967-73.
5. Azar RR, McKay RG, Kiernan FJ, Seecharran B, Feng YJ, Fram DB, et al. Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol 1997;80:1476-8.
6. Serrano CV, Ramires JAF, Venturinelli M, Arie S, D'Amico E, Zweier JL, et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol 1997;29:1276-83.
7. Liuzzo G, Buffon A, Biasucci LM, Gallimore JR, Caligiuri G, Vitelli A, et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998;98:2370-6.
8. Sanchez-Margalet V, Cubero JM, Martin-Romero C, Cubero J, Cruz-Fernandez JM, Goberna R. Inflammatory response to coronary stent implantation in patients with instable angina. Clin Chem Lab Med 2002;40:769-74.
9. Ikeda H, Nakayama H, Oda T, Kuwano K, Yamaga A, Ueno T, et al. Neutrophil activation after percutaneous transluminal coronary angioplasty. Am Heart J 1994;128:1091-8.
10. Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Takabatake Y. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996;28:1127-33.
11. Mickelson JK, Lakkis NM, Villareal-Levy G, Hughes BJ, Smith CW. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease. J Am Coll Cardiol 1996;28:345-53.
12. Inoue T, Sakai Y, Fujito T, Hoshi K, Hayashi T, Takayanagi K, et al. Clinical significance of neutrophil adhesion molecules expression after coronary angioplasty on the development of restenosis. Thromb Haemost 1998;79:54-8.
13. Blum A, Sclarovsky S, Shoat B. T lymphocyte activation in stable angina pectoris and after percutaneous transluminal coronary angioplasty. Circulation 1995;91:20-2.
14. Sluiter W, Pietersma A, Lamers JMJ, Koster JF. Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression. J Cardiovasc Pharmacol 1993;22:S37-S44.
15. Bienvenu K, Granger DN. Molecular determinants of shear rate-dependent leukocyte adhesion in postcapillary venules. Am J Physiol 1993;264:H1504-8.
16. Luscinskas FW, Brock AF, Arnaout MA, Gimbrone Jr MA. Endothelial-leukocyte adhesion molecule-1-dependent and leukocyte (CD11/CD18)-dependent mechanisms contribute to polymorphonuclear leukocyte adhesion to cytokine-activated human vascular endothelium. J Immunol 1989;142:2257-63.
17. Sanchez-Madrid F, Nagy JA, Robbins E, Simon P, Springer TA. A human leukocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1) and the p150,95 molecule. J Exp Med 1983;158:1785-803.
18. Ding ZM, Babensee JE, Simon SI, Lu H, Perrard JL, Bullard DC, et al. Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J Immunol 1999;163:5029-38.
19. Arnaout MA, Lanier LL, Faller DV. Relative contribution of the leukocyte molecules Mo1, LFA-1, and p150,95 (Lew M5) in adhesion of granulocytes and monocytes to vascular endothelium is tissue- and stimulus-specific. J Cell Physiol 1988;137:305-9.
20. Freuyer DR, Morganroth ML, Todd RF. Surface Mo1 (CD11b/CD18) glycoprotein is upmodulated by neutrophils recruited to sites of inflammation in vivo. Inflammation 1989;13:495-505.
21. Jackson DG, Bell JI. Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation. J Immunol 1990; 144:2811-5.
22. Musso T, Deaglio S, Franco L, Calosso L, Badolato R, Garbarino G, et al. CD38 expression and functional activities are up-regulated by IFN-gamma on human monocytes and monocytic cell lines. J Leukoc Biol 2001; 69:605-12.
23. McCloskey TW, Cavaliere T, Bakshi S, Harper R, Fagin J, Kohn N, et al. Immunophenotyping of T lymphocytes by three-color flow cytometry in healthy newborns, children and adults. Clin Immunol Immunopathol 1997;84:46-55.
24. Sirera R, Bayona A, Carbonell F, Pérez-Tamarit D, Otero MC, Asensi F, et al. The expression of CD38 and DR are markers of immune activation and disease progression in HIV+ children. XII International Conference on AIDS. Geneva [abstract 213/31166], Jun 28-Jul 8, 1998.
25. Caligiuri G, Liuzzo G, Biasucci LM, Maseri A. Immune system activation follows inflammation in unstable angina: pathogenetic implications. J Am Coll Cardiol 1998;32:1295-304.
26. Blum A, Sclarovsky S, Shohat B. T lymphocyte activation in stable angina pectoris and after percutaneous transluminal coronary angioplasty. Circulation 1995;91:20-2.
27. Santos-Alvarez J, Goberna R, Sánchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 1999;194:6-11.
28. Libby P. Molecular basis of the acute coronary syndromes. Circulation 1995;91:2844-50.
29. Inoue T, Sohma R, Miyasaki T, Iwasaki Y, Yaguchi I, Morooka S. Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris. Am J Cardiol 2000;86:1057-62.
30. Inoue T, Uchida T, Yaguchi I, Sakai Y, Takayanagi K, Morooka S. Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis. Circulation 2003;107:1757-63.
31. Ikeda U, Matsui K, Murakami Y, Shimada K. Monocyte chemoattractant protein-1 and coronary artery disease. Clin Cardiol 2002;25:143-7.
32. Berliner S, Rogowski O, Rotstein R, Fusman R, Shapira I, Bornstein NM, et al. Activated polymorphonuclear leukocytes and monocytes in the peripheral blood of patients with ischemic heart and brain conditions correspond to the presence of multiple risk factors for atherothrombosis. Cardiology 2000;94:19-25.
33. Mazzone A, De Servi S, Vezzoli M, Fossati G, Mazzucchelli I, Gritti D, et al. Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis 1999;145:369-74.
34. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000;101:2883-8.
35. De Servi S, Mazzone A, Ricevuti G, Mazzucchelli I, Fossati G, Gritti D, et al. Clinical and angiographic correlates of leukocyte activation in unstable angina. J Am Coll Cardiol 1995;26:1146-50.